Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sanofi Takes On Infringing Look-Alike In India

Executive Summary

Sanofi has sought to block an alleged infringer's attempt to ride on its trademarks, trade name and logo in India; the French multinational views these activities as intended to cause confusion among consumers.

You may also be interested in...



Sun Wards Off Volini Infringers, Makes It Count Too

Sun Pharma has blocked a group of firms attempting to ride on the trademark of its popular pain relief brand Volini –  among the key products at the core of the Indian firm’s OTC business.

Sun Wards Off Volini Infringers, Makes It Count Too

Sun Pharma has blocked a group of firms attempting to ride on the trademark of its popular pain relief brand Volini –  among the key products at the core of the Indian firm’s OTC business.

How Sanofi Is ‘Playing To Win’ In India, Watch Diabetes Space

Sanofi India managing director Rodolfo Hrosz talks to Scrip about the company’s refreshed India strategy including in the competitive diabetes segment, which is expected to see a flurry of new product activity. While Soliqua has hit the market, all eyes are also on Novo Nordisk’s Awiqli and Cipla’s partnered inhaled insulin in the wings.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC123244

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel